The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...

A paradigm-shifting study from the Centre for Addiction and Mental Health (CAMH) shows an experimental drug, GL-II-73, has ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...

The coroners service said the number of deaths was a 13-per cent drop over 2023, but it remains well above the 1,776 ...

In separate negotiations, Canadian Prime Minister Justin Trudeau and Mexican President Claudia Sheinbaum have agreed with U.S ...

A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...

Brain cancer is the second-leading cause of death in children in the developed world. For the children who survive, standard ...

Once you turn 65, you’re generally entitled to Medicare coverage. But you don’t have to stick with original Medicare (Parts A ...

These launches are positioned for multi-blockbuster status, thanks to their promise of fulfilling unmet needs, impacting ...

CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.

In 2025, we may see radical top-down changes to our healthcare system as new heads of the NIH - National Institutes of Health ...